ReGen III Executes MOU with U.S. Base Oil and Lubricants Blender and Provides Patents Update

Executive Summary

• ReGen III Corp. signed a non‑binding MOU with a U.S. base‑oil and lubricants blender to establish a framework for a multi‑year definitive off‑take agreement covering Group III and Group II+ base oils.
• The MOU now represents roughly 50% or more of the anticipated production capacity from ReGen III’s planned U.S. facilities, expanding its offtake portfolio.
• The company added new patents in Brazil, Australia, Mexico, Indonesia and South Korea, bringing its total issued patents to 42 with seven pending, strengthening its global IP position.

Key Details

• MOU Partner: Unnamed U.S.-based base‑oil and lubricants blender serving automotive, industrial, and specialty markets.
• Scope of MOU: Provides a detailed commercial framework toward a definitive multi‑year off‑take agreement for ReGen III’s Group III and Group II+ base oils.
• Capacity Coverage: The executed MOU portfolio now covers ≈50% or more of the estimated base‑oil production capacity from U.S. facilities under ReGen III’s commercialization strategy.
• Non‑binding Nature: The agreement is non‑binding; execution of a definitive contract remains subject to further negotiation and documentation. No guarantee that a final agreement will be reached.
• Patent Portfolio Expansion: New patent certificates issued in Brazil, Australia, Mexico; applications granted/allowed in Indonesia and South Korea. Total issued patents now 42; seven additional applications pending.
• Strategic Impact: Enhances ReGen III’s freedom to operate and competitive positioning in global lubricant markets; supports path toward commercialization and long‑term shareholder value.

Notable Quotes

“This MOU further reinforces the strong and growing interest from established North American lubricant market participants in ReGen III's base oils,” said Tony Weatherill, President and Chief Executive Officer.
“Together with our expanding global patent portfolio, these commercial developments continue to advance our path toward commercialization and strengthen the foundation for long‑term shareholder value.”